B. Klosterhalfen et al., LOCAL AND SYSTEMIC INFLAMMATORY MEDIATOR RELEASE IN PATIENTS WITH ACUTE AND CHRONIC POSTTRAUMATIC OSTEOMYELITIS, The journal of trauma, injury, infection, and critical care, 40(3), 1996, pp. 372-378
The local and systemic release of thromboxane A(2), prostaglandin I-2,
leukotriene B-4 (LTB(4)), tumor necrosis factor alpha (TNF-alpha), in
terleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and interleukin-8
(IL-8) were studied before and after operation in 29 patients with acu
te and 22 with chronic posttraumatic osteomyelitis, Twenty patients wi
thout osteomyelitis, who underwent operations for fractures of the low
er extremities, served as controls. Blood and tissue samples from the
osteomyelitic and control groups were collected under defined conditio
ns and mediators were determined by radioimmunoassay (thromboxane B-2,
6-keto-prostaglandin F-1 alpha, LTB(4)) or by enzyme-linked immunosor
bent assay (TNF-alpha, IL-1 beta, IL-6, and IL-8). In addition, common
parameters (leukocyte count, C-reactive protein, temperature) were me
asured. The best correlation with acute disease activity was given by
TNF-alpha, IL-6, IL-8, and LTB(4). Plasma levels of these mediators in
acute osteomyelitis were significantly increased compared to chronic
osteomyelitis and to controls, respectively. Tissue samples from the o
steomyelitic focus shelved significantly increased levels for IL-8, IL
-6, TNF-alpha, IL-1 beta, and LTB(4) in acute osteomyelitis, whereas t
he values for TxB(2) and 6-keto-prostaglandin F-1 alpha were only slig
htly increased compared to the chronic osteomyelitis group, This study
describes the local and systemic liberation of various mediators in a
cute and chronic posttraumatic osteomyelitis in detail for the first t
ime and provides data for pre- and postoperative monitoring of disease
activity and demonstrates new pathogenetic and therapeutic aspects of
bane modulation in osteomyelitis.